Source: China Quality News Network
On August 31, 2022, the Jiangxi Provincial Food and Drug Administration website released the Jiangxi Province 2022 Phase 4 Drug Supervision and Sampling Information Announcement (2022 Phase 4, 81 in total).
announced that in order to strengthen drug quality supervision and ensure public drug safety, in accordance with the " Drug Administration Law " and relevant laws and regulations and the Jiangxi Province drug sampling plan, Jiangxi Province drug regulatory departments and inspection agencies at all levels have conducted inspections on drug production and production in the province. Operation and user units have implemented supervision and random inspections.
After verification and confirmation, the supervision and sampling information of this issue is announced as follows: Jianweixiaoshi tablets and other 11 batches do not meet the regulations . Non-compliance items include properties, moisture, loading differences, weight differences, content determination, etc.
The Jiangxi Provincial Food and Drug Administration has instructed relevant departments to take necessary control measures such as sealing, detaining, suspending sales, and recalling drugs that do not meet the regulations, and investigate and deal with production enterprises and sampled units in accordance with relevant laws and regulations.
source/China Quality News Network
